460 related articles for article (PubMed ID: 31365319)
21. Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.
Martinez TL; Kong L; Wang X; Osborne MA; Crowder ME; Van Meerbeke JP; Xu X; Davis C; Wooley J; Goldhamer DJ; Lutz CM; Rich MM; Sumner CJ
J Neurosci; 2012 Jun; 32(25):8703-15. PubMed ID: 22723710
[TBL] [Abstract][Full Text] [Related]
22. Limited phenotypic effects of selectively augmenting the SMN protein in the neurons of a mouse model of severe spinal muscular atrophy.
Lee AJ; Awano T; Park GH; Monani UR
PLoS One; 2012; 7(9):e46353. PubMed ID: 23029491
[TBL] [Abstract][Full Text] [Related]
23. Dual SMN inducing therapies can rescue survival and motor unit function in symptomatic ∆7SMA mice.
Kray KM; McGovern VL; Chugh D; Arnold WD; Burghes AHM
Neurobiol Dis; 2021 Nov; 159():105488. PubMed ID: 34425216
[TBL] [Abstract][Full Text] [Related]
24. Temporal requirement for SMN in motoneuron development.
Hao le T; Duy PQ; Jontes JD; Wolman M; Granato M; Beattie CE
Hum Mol Genet; 2013 Jul; 22(13):2612-25. PubMed ID: 23459934
[TBL] [Abstract][Full Text] [Related]
25. Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration.
Arnold WD; Duque S; Iyer CC; Zaworski P; McGovern VL; Taylor SJ; von Herrmann KM; Kobayashi DT; Chen KS; Kolb SJ; Paushkin SV; Burghes AH
PLoS One; 2016; 11(12):e0167077. PubMed ID: 27907033
[TBL] [Abstract][Full Text] [Related]
26. Interaction between alpha-COP and SMN ameliorates disease phenotype in a mouse model of spinal muscular atrophy.
Custer SK; Astroski JW; Li HX; Androphy EJ
Biochem Biophys Res Commun; 2019 Jun; 514(2):530-537. PubMed ID: 31060774
[TBL] [Abstract][Full Text] [Related]
27. On the possible role of muscle in the pathogenesis of spinal muscular atrophy.
Guettier-Sigrist S; Coupin G; Braun S; Rogovitz D; Courdier I; Warter JM; Poindron P
Fundam Clin Pharmacol; 2001 Feb; 15(1):31-40. PubMed ID: 11468011
[TBL] [Abstract][Full Text] [Related]
28. SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of spinal muscular atrophy.
Khairallah MT; Astroski J; Custer SK; Androphy EJ; Franklin CL; Lorson CL
Hum Mol Genet; 2017 Mar; 26(5):932-941. PubMed ID: 28062667
[TBL] [Abstract][Full Text] [Related]
29. Defects in Motoneuron-Astrocyte Interactions in Spinal Muscular Atrophy.
Zhou C; Feng Z; Ko CP
J Neurosci; 2016 Feb; 36(8):2543-53. PubMed ID: 26911699
[TBL] [Abstract][Full Text] [Related]
30. Fishing for a mechanism: using zebrafish to understand spinal muscular atrophy.
Beattie CE; Carrel TL; McWhorter ML
J Child Neurol; 2007 Aug; 22(8):995-1003. PubMed ID: 17761655
[TBL] [Abstract][Full Text] [Related]
31. A new model to study spinal muscular atrophy: neurite degeneration and cell death is counteracted by BCL-X(L) Overexpression in motoneurons.
Garcera A; Mincheva S; Gou-Fabregas M; Caraballo-Miralles V; Lladó J; Comella JX; Soler RM
Neurobiol Dis; 2011 Jun; 42(3):415-26. PubMed ID: 21333739
[TBL] [Abstract][Full Text] [Related]
32. Spinal Muscular Atrophy autophagy profile is tissue-dependent: differential regulation between muscle and motoneurons.
Sansa A; Hidalgo I; Miralles MP; de la Fuente S; Perez-Garcia MJ; Munell F; Soler RM; Garcera A
Acta Neuropathol Commun; 2021 Jul; 9(1):122. PubMed ID: 34217376
[TBL] [Abstract][Full Text] [Related]
33. Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy.
Bowerman M; Murray LM; Boyer JG; Anderson CL; Kothary R
BMC Med; 2012 Mar; 10():24. PubMed ID: 22397316
[TBL] [Abstract][Full Text] [Related]
34. Combinatorial ASO-mediated therapy with low dose SMN and the protective modifier Chp1 is not sufficient to ameliorate SMA pathology hallmarks.
Muinos-Bühl A; Rombo R; Janzen E; Ling KK; Hupperich K; Rigo F; Bennett CF; Wirth B
Neurobiol Dis; 2022 Sep; 171():105795. PubMed ID: 35724821
[TBL] [Abstract][Full Text] [Related]
35. Defects in neuromuscular junction remodelling in the Smn(2B/-) mouse model of spinal muscular atrophy.
Murray LM; Beauvais A; Bhanot K; Kothary R
Neurobiol Dis; 2013 Jan; 49():57-67. PubMed ID: 22960106
[TBL] [Abstract][Full Text] [Related]
36. The phospho-landscape of the survival of motoneuron protein (SMN) protein: relevance for spinal muscular atrophy (SMA).
Detering NT; Schüning T; Hensel N; Claus P
Cell Mol Life Sci; 2022 Aug; 79(9):497. PubMed ID: 36006469
[TBL] [Abstract][Full Text] [Related]
37. Tissue-specific models of spinal muscular atrophy confirm a critical role of SMN in motor neurons from embryonic to adult stages.
Laird AS; Mackovski N; Rinkwitz S; Becker TS; Giacomotto J
Hum Mol Genet; 2016 May; 25(9):1728-38. PubMed ID: 26908606
[TBL] [Abstract][Full Text] [Related]
38. Spinal muscular atrophy and the antiapoptotic role of survival of motor neuron (SMN) protein.
Anderton RS; Meloni BP; Mastaglia FL; Boulos S
Mol Neurobiol; 2013 Apr; 47(2):821-32. PubMed ID: 23315303
[TBL] [Abstract][Full Text] [Related]
39. Advances in modeling and treating spinal muscular atrophy.
Van Alstyne M; Pellizzoni L
Curr Opin Neurol; 2016 Oct; 29(5):549-56. PubMed ID: 27472505
[TBL] [Abstract][Full Text] [Related]
40. Induction of Survival of Motor Neuron (SMN) Protein Deficiency in Spinal Astrocytes by Small Interfering RNA as an In Vitro Model of Spinal Muscular Atrophy.
Leo M; Schmitt LI; Fleischer M; Steffen R; Osswald C; Kleinschnitz C; Hagenacker T
Cells; 2022 Feb; 11(3):. PubMed ID: 35159369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
